Skip to content

Randomised trial, 2023

Are there new drug treatments for PMDD besides SSRIs?

Yes. A new class of drugs called selective progesterone receptor modulators, specifically ulipristal acetate, significantly reduced PMDD mental symptoms compared to placebo with minimal side effects. More research is needed on long-term safety.

Early or limited evidence General review of PMDD treatment approaches across multiple studies

What they did

This review article examined current and new drug treatments for PMDD. The authors discussed how SSRIs work, the role of sex hormone changes in PMDD, and how newer drugs approach the problem differently by modifying hormone effects rather than regulating serotonin.

What they found

SSRIs help many but not all people with PMDD. Ulipristal acetate, a selective progesterone receptor modulator, was compared to placebo in a randomized controlled trial and showed clinically significant reduction in PMDD mental symptoms with negligible side effects. The treatment produced stable, low progesterone levels.

What it means for you

New hormone-targeting approaches may help women with PMDD who don't respond to SSRIs. SPRM trial results are promising and bring us closer to understanding PMDD. However, larger and longer studies are needed on long-term safety and practicality for women of reproductive age. This remains exploratory, not yet a proven SSRI alternative.

5%

of women affected by PMDD

SPRM drug tested

ulipristal acetate

Negligible

side effects with treatment

About the study

Original title
New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder
Authors
Sundström-Poromaa I, Comasco E
Journal
CNS drugs
Year
2023
Study design
Randomised trial
Open access
Yes

Topics